4 Result(s)

Article

Hairy cell leukemia variant and WHO classification correspondence Re: 5^th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons… in Leukemia (2024)

Article

Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy

Pooja S. Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J. Pollauf, Amy Zheng… in Leukemia (2023)

Article

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). Ho...

Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos… in Blood Cancer Journal (2022)

Article

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

Post-market analyses revealed unanticipated links between first-generation Bruton’s tyrosine kinase inhibitor (BTKi) therapy, ibrutinib, and profound early hypertension. Yet, whether this is seen with novel se...

Sunnia T. Chen, Leylah Azali, Lindsay Rosen… in Journal of Hematology & Oncology (2022)